KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Cash from Financing Activities (2017 - 2025)

Guardant Health's Cash from Financing Activities history spans 9 years, with the latest figure at $732.0 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities rose 25041.33% year-over-year to $732.0 million; the TTM value through Dec 2025 reached $671.1 million, up 67482.83%, while the annual FY2025 figure was $671.1 million, 67482.83% up from the prior year.
  • Cash from Financing Activities for Q4 2025 was $732.0 million at Guardant Health, up from $4.3 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $732.0 million in Q4 2025 and bottomed at -$172.1 million in Q2 2022.
  • The 5-year median for Cash from Financing Activities is $806000.0 (2022), against an average of $44.6 million.
  • The largest annual shift saw Cash from Financing Activities plummeted 7016.67% in 2023 before it soared 25041.33% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at $3.8 million in 2021, then crashed by 38.68% to $2.3 million in 2022, then surged by 3807.16% to $90.6 million in 2023, then tumbled by 103.24% to -$2.9 million in 2024, then skyrocketed by 25041.33% to $732.0 million in 2025.
  • Per Business Quant, the three most recent readings for GH's Cash from Financing Activities are $732.0 million (Q4 2025), $4.3 million (Q3 2025), and $1.6 million (Q2 2025).